Edesa Biotech

Canada
Canada, Markham, Ontario
(905)-475 1234 ★

Company profile

Edesa Biotech company profile

Edesa Biotech is a clinical-stage private company focused on developing treatments for dermatological and anorectal diseases. The initial focus is on developing novel, safe and potent alternatives to steroids for Allergic Contact Dermatitis, Hemorrhoids, and Anal Fissures. Edesa Biotech’s lead asset, EB01 is a novel non-steroidal anti-inflammatory molecule for the treatment of allergic contact dermatitis which has already demonstrated statistically significant improvements in multiple clinical studies.

Business identity

Contact email
[email protected]
Phone number
(905)-475 1234
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2015-01-01

Headquarters

Headquarters
Canada, Markham, Ontario
Postal code
L3R 5H6
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
9
Total equity funding
$45.3M
Last funding
Post Ipo Equity / $3.4M / 2025-09-30
Last equity funding
Post Ipo Equity / $3.4M
Investors
11
Lead investors
4
Founders
1
Articles
117
Exited on
2019-06-10

Founders and investors

Founders

Par Nijhawan

Lead investors

Government of CanadaLumira VenturesStrategic Innovation FundVelan Capital

Investors

Government of CanadaInvereadyLumira VenturesNantahala Capital ManagementPharmascience

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.